Bal Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 25	Sep ' 24	Sep ' 23	Sep ' 22	Mar ' 22

Sales

139.38

147.83

162.47

144.56

142.75

Operating profit

11.93

14.53

14.50

11.46

9.59

Interest

7.91

7.89

7.46

5.20

4.80

Gross profit

5.89

7.83

7.90

7.20

9.84

EPS (Rs)

0.69

1.86

1.78

1.63

2.69

Other income

1.88

1.19

0.86

0.94

5.05

Stock adjustment

-8.67

-1.06

-4.44

-8.76

-2.95

Raw material

76.32

72.43

91.76

87.83

82.83

Power and fuel

-

-

-

-

-

Employee expenses

30.82

28.73

27.38

25.00

23.77

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

28.99

33.20

33.27

29.03

29.51

Provisions made

-

-

-

-

-

Depreciation

4.79

4.19

4.14

3.79

3.83

Taxation

-

0.68

0.97

0.87

2.02

Net profit / loss

1.10

2.96

2.80

2.54

3.99

Extra ordinary item

-

-

-

-

-0.01

Prior year adjustments

-

-

-

-

-

Equity capital

15.92

15.92

15.69

15.57

14.82

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

8.56

9.83

8.92

7.93

6.72

GPM (%)

4.17

5.25

4.84

4.95

6.65

NPM (%)

0.78

1.99

1.71

1.74

2.70